FASN and lung carcinoma: Moreover, microarray data from Kaplan–Meier plotter (n = 1926) indicated the prognostic role of FASN expression in lung cancer patients (HR = 1.81, 95% CI: 1.47–2.21, adjusted for clinical stage) (Fig. S6B).